WebFeb 22, 2021 · Sitafloxacin works primarily by inhibiting the activity of DNA gyrase and topoisomerase IV with broad spectrum antimicrobial activity against gram-positive bacteria such as S....
WebApr 16, 2011 · Sitafloxacin is a fluoroquinolone antibacterial with in vitro activity against a broad range of Gram-positive and -negative bacteria, including anaerobic bacteria, as...
WebJul 28, 2018 · The susceptibility breakpoint for delafloxacin against Staphylococcushemolyticus and enterobacteriaceae is ≤0.25 µg/mL, with intermediate...
WebFeb 7, 2018 · Delafloxacin is a novel anionic fluoroquinolone (FQ) approved for treatment of acute bacterial skin and skin structure infections (ABSSSIs) caused by a number of...
WebDec 17, 2020 · This is a randomized, open-label, active-controlled multicentre phase 3 clinical trial designed to evaluate the efficacy and safety of sitafloxacin versus...
WebJul 11, 2012 · Sitafloxacin (DU-6859a) is a new-generation oral fluoroquinolone with in vitro activity against a broad range of Gram-positive and -negative bacteria, including anaerobic bacteria,...












